Latham & Watkins advised SMART Global Holdings Inc. SMART Global Holdings, Inc. closed a US$175 million in aggregate principal amount of convertible senior notes due 2030,...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises MindMed in growth financing with K2 HealthVentures. Mind Medicine Inc. (MindMed), a clinical stage biopharmaceutical company developing novel product candidates to treat...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises on Heron Therapeutics’ working capital credit facility. Heron Therapeutics, Inc. (Heron), a commercial-stage biotechnology company focused on improving the lives of patients...
You must be a Standard 1 Year member to access this content.
Latham & Watkins Advises on Air Transport Services Group’s Convertible Senior Notes Offering. Air Transport Services Group, Inc. (NASDAQ: ATSG) has announced the pricing of its...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Outset, while Latham & Watkins LLP represented SLR Capital Partners in the transaction. Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Hercules Capital, Inc. in the transaction. Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Hercules in the transaction. Tricida, Inc. (Nasdaq: TCDA) has entered into a debt facility with Hercules Capital, Inc. (NYSE: HTGC), a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Spectrum Pharmaceuticals in the deal. Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, has entered into...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Alignment Healthcare in the transaction. Alignment Healthcare, Inc.(Alignment Healthcare) (NASDAQ: ALHC), a leading tech-enabled MedicareAdvantage company, has announced the close of an...
You must be a Standard 1 Year member to access this content.
Latham & Watkins and Conyers represented Marti Technologies Inc. in the transaction. Willkie Farr & Gallagher represented Galata. White & Case represented B. Riley Securities. Galata Acquisition...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Rhythm Pharmaceuticals, Inc. in the transaction, while Morgan, Lewis & Bockius acted as legal advisor to HealthCare Royalty. Rhythm Pharmaceuticals, Inc. (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Arcutis in the transaction. Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing novel innovations in immuno-dermatology, has announced that...
You must be a Standard 1 Year member to access this content.
